Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Hargreaves

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurourology and Urodynamics|July 21, 2021
Acupuncture in addition to standard conservative treatment for overactive bladder; a feasibility trial for a randomized controlled studyEmma Hargreaves, Chris Harding, Carl Clarkson
The Cochrane Database of Systematic Reviews|September 23, 2022
Acupuncture for treating overactive bladder in adultsEmma Hargreaves, Katherine Baker, Gill Barry, et al.
Elife|January 23, 2024
Using reflective practice to support PhD students in the biosciencesJennifer Tullet, Jennifer Leigh, Brandon Coke, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurourology and Urodynamics|July 21, 2021
Acupuncture in addition to standard conservative treatment for overactive bladder; a feasibility trial for a randomized controlled studyEmma Hargreaves, Chris Harding, Carl Clarkson
The Cochrane Database of Systematic Reviews|September 23, 2022
Acupuncture for treating overactive bladder in adultsEmma Hargreaves, Katherine Baker, Gill Barry, et al.
Elife|January 23, 2024
Using reflective practice to support PhD students in the biosciencesJennifer Tullet, Jennifer Leigh, Brandon Coke, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Pageof 1